Miami, FL, United States of America

Pascal J Goldschmidt

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Chapel Hill, NC (US) (2010)
  • Miami, FL (US) (2010 - 2012)

Company Filing History:


Years Active: 2010-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Pascal J Goldschmidt**

Introduction

Pascal J Goldschmidt is a prominent inventor based in Miami, Florida, with a focus on advancements in cardiovascular health. With three patents to his name, he has made significant contributions to the understanding and identification of genetic markers associated with coronary artery disease. His work has the potential to change the landscape of cardiovascular disease management considerably.

Latest Patents

Goldschmidt's latest inventions revolve around methods for identifying individuals at increased risk of developing coronary artery disease. One notable patent outlines a process for assessing a subject's risk by correlating the presence of specific genetic markers located in chromosome 3q13.31. This innovative approach not only identifies individuals at risk but also aids in determining their prognosis and effective treatment regimens based on genetic correlations.

Career Highlights

Currently, Pascal J Goldschmidt is affiliated with Duke University, where he continues to conduct impactful research on cardiovascular diseases. His expertise in genetics and disease prevention has positioned him as a leader in his field, ensuring that advancements in medical science benefit communities and healthcare systems alike.

Collaborations

Throughout his career, Goldschmidt has collaborated with esteemed colleagues, including Jeffery M Vance and William E Kraus. These partnerships have enriched his research endeavors and allowed for a multidisciplinary approach to tackling complex health issues, particularly those related to heart disease.

Conclusion

Pascal J Goldschmidt's innovations play a crucial role in enhancing our understanding of cardiovascular diseases and their genetic underpinnings. His patents not only pave the way for improved risk assessment and prognostic capabilities but also reflect his commitment to advancing medical science for better health outcomes. As he continues his work at Duke University, the potential for future discoveries remains vast, promising further breakthroughs in cardiovascular health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…